Learn about our recent developments
.svg)
CAMBRIDGE, MASSACHUSETTS, May 12, 2025— Origin Medical, a pioneer in advancing AI in prenatal care, has announced its first appearance as an exhibitor at the upcoming ACOG Annual Clinical and Scientific Meeting (ACSM), taking place from May 16–18, 2025 at the Minneapolis Convention Center, Minneapolis, MN.
Visitors to booth #347 will get an exclusive first look at Origin Medical EXAM ASSISTANTTM, Origin Medical’s flagship AI solution designed to help physicians and ultrasound professionals deliver exceptional prenatal care every time.
“We’re excited to introduce our real-time AI solutions to the ACOG community,” said Sripad Krishna Devalla, PhD, Co-founder and CTO of Origin Medical. “Our goal is to empower healthcare professionals to improve efficiency and maintain high quality of care by helping them optimize imaging workflows — and we can’t wait to share that vision at ACSM.”
“Origin Medical shares ACOG’s commitment to improving the lives of those seeking obstetric and gynecologic care. We are proud to join thousands of OB-GYNs and healthcare leaders as we work towards our mission to advance maternal health equity and improve access to prenatal care with the AI.” added Jens Thang, Co-founder and CEO.
As part of its ACSM debut, Origin Medical will exhibit in the Innovation Lane and deliver a featured presentation on May 16 at 3:45 PM CT.
To learn more or schedule a meeting with the Origin Medical team at the Annual Clinical and Scientific Meeting, contact us here.
CAMBRIDGE, MASSACHUSETTS, June 5, 2024 — Origin Medical, a pioneer in advancing AI in prenatal care, has announced the addition of Stephen Bruso of Morningside Ventures and Mike Butler, former President of Providence Health, to its Board of Directors.
“We are thrilled to welcome Stephen and Mike to our Board of Directors," said Jens Thang, co-founder and CEO of Origin Medical. "Both bring a unique perspective and wealth of experience that will be instrumental in steering our company towards our mission of advancing maternal health equity by improving access to quality prenatal care with AI."
Stephen Bruso plays a significant role at Morningside Ventures, where his expertise lies in investments within the biopharma and digital health sectors. Morningside is a technology and life science venture investment firm founded in 1986 by the Chan family. The firm focuses on start-up technology companies founded on novel scientific discoveries and has an investment footprint in North America, Europe, and Greater China. The founders of Morningside made a gift to Harvard University, which renamed its public health school the Harvard T.H. Chan School of Public Health.
Mike Butler has served in several key executive positions, including President, COO, and CFO, during his tenure at Providence Health. Under his guidance, the organization experienced remarkable expansion, growing from a $2 billion organization to generating $25 billion in annual revenue, making it the third-largest health system in the U.S. He currently serves as an operating partner at the private equity firm Welsh, Carson, Anderson, & Stowe, specializing in offering guidance on acquisitions, joint ventures, and strategic investments within the healthcare service and technology sectors.
“It’s an honor to be part of the Origin Medical team and its incredible mission to give every child the opportunity to live the fullest life possible,” said Mike Butler.
About Origin Medical
Origin Medical, headquartered in Cambridge, Massachusetts, USA, is driven by a mission to advance maternal health equity by improving access to quality prenatal care with artificial intelligence.
By combining the knowledge of healthcare and AI, it is on a journey to build state-of-the-art solutions aimed at supporting a broad spectrum of healthcare providers in rural and urban communities, allowing them to practice at the top of their licenses. With AI in the imaging workflow, clinicians can more confidently deliver timely interventions, enhance pregnancy outcomes, identify high-risk pregnancies to reduce maternal mortality, and significantly lower infant mortality rates.
See the full press release here.
CAMBRIDGE, MASSACHUSETTS, May 9, 2024 — Origin Medical, a pioneer in advancing AI in prenatal care, has announced the launch of Origin Medical Research Lab, a research arm that sits at the heart of Origin Medical's innovation ecosystem.
“We are bringing together best-in-class talent in AI and healthcare, alongside robust infrastructure and resources, to foster technological innovations in prenatal care.” said Sripad Krishna Devalla, Ph.D., co-founder and CTO of Origin Medical.
Headquartered in Bengaluru, Karnataka, India, the Origin Medical Research Lab is dedicated to bringing together the best and brightest minds at the intersection of AI and healthcare to fulfill Origin Medical’s mission to advance maternal health equity across the globe.
“We are an AI-first company. The establishment of Origin Medical Research Lab aims to accelerate our research efforts to advance the entire industry forward with breakthroughs in AI development. We’ve shown AI’s potential to address the maternal health crisis and support healthcare providers in providing quality care for every expecting mother.” said Jens Thang, co-founder and CEO of Origin Medical.
About Origin Medical
Origin Medical, headquartered in Cambridge, Massachusetts, USA, is driven by a mission to advance maternal health equity by improving access to quality prenatal care with artificial intelligence.
By combining the knowledge of healthcare and AI, it is on a journey to build state-of-the-art solutions aimed at supporting a broad spectrum of healthcare providers in rural and urban communities, allowing them to practice at the top of their licenses. With AI in the imaging workflow, clinicians can more confidently deliver timely interventions, enhance pregnancy outcomes, identify high-risk pregnancies to reduce maternal mortality, and significantly lower infant mortality rates.
See the full press release here.
CAMBRIDGE, MASSACHUSETTS, April 29, 2024 — Origin Medical, formerly known as Origin Health, a pioneer in advancing AI in prenatal care, has announced a rebrand to evolve alongside the dynamic healthcare industry and reflect the company’s mission and core values.
The company’s new name, Origin Medical, maintains the organization's focus on early life and its commitment to ensure every expectant mother globally receives the highest quality of standardized, reliable prenatal care. This is all made possible through Origin Medical's state-of-the-art AI solutions.
The vibrant hues of blue and white in the new logo symbolize trust, reliability, and transparency—values the company recognizes as paramount in prenatal care, both for expecting mothers and maternal health practitioners. These core values are the guiding principles of Origin Medical's ethos and commitment to the community they serve. The Morse code elements represent the initials 'O', M', 'A', and ‘I’, which stand for Origin, Medical, Artificial, and Intelligence, respectively.
“The rebrand highlights our mission to advance maternal health equity by improving access to quality prenatal care with AI.” said Jens Thang, co-founder and CEO of Origin Medical. “The U.S. is grappling with a growing maternal health crisis, as 7 million women in their childbearing years live in regions lacking sufficient or completely lacking maternity healthcare. We believe that our brand reinforces our commitment to provide quality prenatal care to every mother, regardless of the region.”
“Origin Medical’s ability to create access to highly efficient and effective prenatal care for every expecting mother is one of the most transformational outcomes within US healthcare today.” said Mike Butler, former President of Providence Healthcare, one of the largest health systems in the U.S. “Their technology is enabling a new standard of care that will give every mother and child the opportunity to live the healthiest life possible. In addition to enabling greater access and better outcomes, the company will also lead to a lower lifetime cost of healthcare care in all populations and, most importantly, in those populations served by Medicaid.”
Origin Medical is supported by Origin Medical Research Lab, a research arm that sits at the heart of Origin Medical's innovation ecosystem, bringing together the brightest minds at the intersection of AI and healthcare to fulfill Origin Medical’s mission to advance maternal health equity across the globe.
About Origin Medical
Origin Medical, headquartered in Cambridge, Massachusetts, USA, is driven by a mission to advance maternal health equity by improving access to quality prenatal care with artificial intelligence.
By combining the knowledge of healthcare and AI, it is on a journey to build state-of-the-art solutions aimed at supporting a broad spectrum of healthcare providers in rural and urban communities, allowing them to practice at the top of their licenses. With AI in the imaging workflow, clinicians can more confidently deliver timely interventions, enhance pregnancy outcomes, identify high-risk pregnancies to reduce maternal mortality, and significantly lower infant mortality rates.
See the full press release here.
CAMBRIDGE, MASSACHUSETTS, October 2, 2021 — Origin Health, a pioneer in advancing AI in prenatal care, has been awarded the Affordable Care Award at the MICCAI Startup Village 2021.
The award, presented in collaboration with FAIR (Affordable Healthcare and AI for Resource Diverse Global Health), aligns with MICCAI's (Medical Image Computing & Computer Assisted Intervention) emphasis on affordability and accessibility in healthcare. Origin Health emerged as the winner, highlighting its innovative approach to addressing critical healthcare challenges.
This accolade reaffirms Origin Health's mission to advance maternal health equity by improving access to quality prenatal care with AI. By leveraging cutting-edge technology and a commitment to affordability, Origin Health continues to move towards revolutionizing prenatal care.
About Origin Health
Origin Health, headquartered in Cambridge, Massachusetts, USA, is driven by a mission to advance maternal health equity by improving access to quality prenatal care with artificial intelligence.
By combining the knowledge of healthcare and AI, it is on a journey to build state-of-the-art solutions aimed at supporting a broad spectrum of healthcare providers in rural and urban communities, allowing them to practice at the top of their licenses. With AI in the imaging workflow, clinicians can more confidently deliver timely interventions, enhance pregnancy outcomes, identify high-risk pregnancies to reduce maternal mortality, and significantly lower infant mortality rates.
CAMBRIDGE, MASSACHUSETTS, June 23, 2022 — Origin Health, a pioneer in advancing AI in prenatal care, has announced their acceptance in the Texas Medical Center Innovation (TMCi) Accelerator for Health Tech Spring 2022 Cohort.
The Texas Medical Center (TMC), comprising over 60 esteemed member institutes, serves as a hub for collaboration and innovation within the healthcare industry. Through its collaborative efforts, TMC accelerates the progress of health technology companies, pushing the frontiers of healthcare delivery to new heights.
“Origin Health is excited to be a part of TMCi and engage with the world’s largest medical city to democratize the global standard of care for every expectant mother by bringing expert-level prenatal screening to them.” said Dr. Sripad Krishna Devalla, co-founder and CTO of Origin Health.
The TMC Innovation Accelerator offers a unique platform for participant companies, facilitating the convergence of diverse perspectives from payers, providers, regulatory bodies, reimbursement agencies, and seasoned health tech entrepreneurs. This collaborative environment fosters innovation and empowers companies to scale their solutions effectively.
“Origin Health recognizes the significance of being part of the thriving Houston health tech landscape facilitated by TMC Innovation.” said Jens Thang, co-founder and CEO of Origin Health. “By connecting with top minds in science and medicine across TMC’s member institutions, we aim to contribute to the advancement of maternal health equity by improving access to quality prenatal care with AI.”
About Origin Health
Origin Health, headquartered in Cambridge, Massachusetts, USA, is driven by a mission to advance maternal health equity by improving access to quality prenatal care with artificial intelligence.
By combining the knowledge of healthcare and AI, it is on a journey to build state-of-the-art solutions aimed at supporting a broad spectrum of healthcare providers in rural and urban communities, allowing them to practice at the top of their licenses. With AI in the imaging workflow, clinicians can more confidently deliver timely interventions, enhance pregnancy outcomes, identify high-risk pregnancies to reduce maternal mortality, and significantly lower infant mortality rates.
CAMBRIDGE, MASSACHUSETTS, June 23, 2022 — Origin Health*, a pioneer in advancing AI in prenatal care, has made a significant mark in the Computational Health stream at Creative Destruction Lab (CDL). The event, held recently, brought together top-tier entrepreneurs, investors, and industry experts to explore groundbreaking ideas and technologies shaping the future of biology, medicine, and healthcare.
Origin Health was among the top ten ventures and the only venture from CDL Seattle to be featured in the CDL Super Session 2022.
At the Super Session, Origin Health captivated attendees with its transformative solutions, illustrating a profound understanding of the fusion between healthcare and technology. By leveraging advanced data analytics, machine learning algorithms, and computational strategies, Origin Health is committed to advancing maternal health equity by improving access to quality prenatal care with their proprietary AI.
“We are honored to have been selected as the sole venture from CDL Seattle to feature in the CDL Super Session 2022," said Jens Thang, co-founder and CEO of Origin Health. "This recognition validates our dedication to democratizing the global standard of care for every expectant mother by bringing expert-level prenatal screening to them.”
The CDL Seattle Super Session serves as a platform for promising startups to connect with experienced mentors, investors, and industry partners to refine their objectives, effectively allocate time and resources, secure funding, expand their networks, and accelerate their growth and impact. Origin Health's participation underscores its commitment to driving innovation and shaping the future of prenatal care
About Origin Health
Origin Health, headquartered in Cambridge, Massachusetts, USA, is driven by a mission to advance maternal health equity by improving access to quality prenatal care with artificial intelligence.
By combining the knowledge of healthcare and AI, it is on a journey to build state-of-the-art solutions aimed at supporting a broad spectrum of healthcare providers in rural and urban communities, allowing them to practice at the top of their licenses. With AI in the imaging workflow, clinicians can more confidently deliver timely interventions, enhance pregnancy outcomes, identify high-risk pregnancies to reduce maternal mortality, and significantly lower infant mortality rates.
*Origin Health is now Origin Medical.